Register now to our Newsletter

* indicates required







Our latest news

TransCure is proud to serve researchers in the field by providing suitable HIV mouse disease models

New H.I.V. long-term remission reported in a second patient, a huge milestone in the Global AIDS Epidemic

TransCure is proud to serve researchers in the field by providing suitable HIV mouse disease models.
The talk about us in the press: LaBiotech

They talk about us in Labiotech – Immuno-Oncology

Find more about how TransCure improves immuno-oncology research with its humanized mouse model.
TransCure - Improving Animal Health with microchip-based identification system

Microchip-based mouse identification system

TransCure bioServices improves animal health and wellbeing by using microchip-based identification system in order to deliver the best quality data to the customers.
TransCure bioServices wishes you a Happy New Year !

2018 achievements and new objectives in 2019

TransCure bioServices shares with you its major achievements in 2018 and its objectives 2019.
TransCure bioServices involved in Targovax's results

TransCure bioServices involved in Targovax’s results

Targovax demonstrates the “Synergistic effect of oncolytic virus combined with anti-PD-1 against Melanoma”. TransCure’s hu-mouse are the preferred in vivo models for combination therapy evaluation.
TransCure bioServices will give a pitch at I4ID2018

TransCure will be waiting you at the second edition of I4ID

Besides being present at I4ID event, Sébastien Tabruyn, our CSO, will give a pitch for answering one question : “How humanized mice models helps to evaluate immunotherapy for infectious Diseases?”
Aquisition of a second flow cytometer TransCure Bioservices

Acquisition of a second flow cytometer

TransCure team has just acquired a second AttuneTM NxT Flow Cytometer. With this new cytometer, the scientific team will be able to carry out more accurate studies, analyze more sample types and expand its capabilities.
2018 Nobel Prize in Medicine Awarded to Cancer Immunotherapy Research - Patrick Nef reacts

2018 Nobel Prize in Medicine, our CEO reacts!

Patrick Nef, CEO at TransCure reacts to Jim Allison and Tasuku Honjo’s awards for their research on immunotherapy.
TransCure bioServices (TCS) hired Antoine POSKIN, Veterinarian, PhD to manage the animal Facilities and get the AAALAC accreditation

TransCure bioServices (TCS) hired Antoine POSKIN, Veterinarian, PhD to manage the animal Facilities and get the AAALAC accreditation

TransCure bioServices (TCS) hired Antoine POSKIN, Veterinarian, PhD to manage the animal Facilities and get the AAALAC accreditation   AAALAC accreditation is a process that demonstrates the use of high standards and state of the art facility (equipment,...
The talk about us in the press: LaBiotech

They talk about us in Labiotech

Find more about TransCure humanized mice models which makes it possible to test novel anti-HIV treatments on infected animal models with a fully functional human immune system!

Share this!